Cargando…
The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study
BACKGROUND: Against a background of rapid increase of β-lactamase-producing or multi-resistant pathogenic bacteria and the resulting lack of effective antibiotic treatment, some older antibiotics have been tested for new therapeutic uses. One of these is fosfomycin, to which according to studies the...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406914/ https://www.ncbi.nlm.nih.gov/pubmed/28446177 http://dx.doi.org/10.1186/s12894-017-0222-6 |
_version_ | 1783232062501683200 |
---|---|
author | Fajfr, Miroslav Louda, Miroslav Paterová, Pavla Ryšková, Lenka Pacovský, Jaroslav Košina, Josef Žemličková, Helena Broďák, Miloš |
author_facet | Fajfr, Miroslav Louda, Miroslav Paterová, Pavla Ryšková, Lenka Pacovský, Jaroslav Košina, Josef Žemličková, Helena Broďák, Miloš |
author_sort | Fajfr, Miroslav |
collection | PubMed |
description | BACKGROUND: Against a background of rapid increase of β-lactamase-producing or multi-resistant pathogenic bacteria and the resulting lack of effective antibiotic treatment, some older antibiotics have been tested for new therapeutic uses. One of these is fosfomycin, to which according to studies these resistant bacteria are very sensitive. Our study was designed because there is no data on the fosfomycin susceptibility rate in the Czech Republic. METHOD: In this study from January 2013 to June 2014 3295 unique isolates of Gram-negative bacteria which had caused urinary tract infections were examined. The antibiotic susceptibility was measured by disk diffusion test. Both EUCAST and CLSI guidelines criteria (for fosfomycin only) were used for the antibiotic susceptibility evaluation. RESULTS: The most frequently tested bacterial isolates were Escherichia coli (51.3%, n = 1703), Klebsiella pneumoniae (19.4%, n = 643) and Proteus spp. (11.8%, n = 392). Among all isolates 29.0% (n = 963) were resistant to fluoroquinolones, 11.3% (n = 374) produced extended spectrum β-lactamase and 4.2% (n = 141) produced AmpC β-lactamase. The overall in vitro susceptibility was significantly higher for fosfomycin compared to the other tested per-oral antibiotics (nitrofurantoin, ampicillin, co-trimoxazole, ciprofloxacin and cefuroxime) against all tested Gram-negative rod isolates (excluding Morganella morgani and Acinetobacter spp. isolates). Fosfomycin also remained highly active against those isolates with extended spectrum β-lactamase (ESBL) production (95.8% in Escherichia coli isolates and 85.3% in Klebsiella pneumoniae isolates), unlike other tested per-oral antibiotics, which showed significant (p < 0.0001) susceptibility decrease. CONCLUSION: We have confirmed in the Czech Republic the very high susceptibility to fosfomycin trometamol of urinary tract infection pathogens, particularly Gram-negative rods including those producing β-lactamase. |
format | Online Article Text |
id | pubmed-5406914 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54069142017-04-27 The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study Fajfr, Miroslav Louda, Miroslav Paterová, Pavla Ryšková, Lenka Pacovský, Jaroslav Košina, Josef Žemličková, Helena Broďák, Miloš BMC Urol Research Article BACKGROUND: Against a background of rapid increase of β-lactamase-producing or multi-resistant pathogenic bacteria and the resulting lack of effective antibiotic treatment, some older antibiotics have been tested for new therapeutic uses. One of these is fosfomycin, to which according to studies these resistant bacteria are very sensitive. Our study was designed because there is no data on the fosfomycin susceptibility rate in the Czech Republic. METHOD: In this study from January 2013 to June 2014 3295 unique isolates of Gram-negative bacteria which had caused urinary tract infections were examined. The antibiotic susceptibility was measured by disk diffusion test. Both EUCAST and CLSI guidelines criteria (for fosfomycin only) were used for the antibiotic susceptibility evaluation. RESULTS: The most frequently tested bacterial isolates were Escherichia coli (51.3%, n = 1703), Klebsiella pneumoniae (19.4%, n = 643) and Proteus spp. (11.8%, n = 392). Among all isolates 29.0% (n = 963) were resistant to fluoroquinolones, 11.3% (n = 374) produced extended spectrum β-lactamase and 4.2% (n = 141) produced AmpC β-lactamase. The overall in vitro susceptibility was significantly higher for fosfomycin compared to the other tested per-oral antibiotics (nitrofurantoin, ampicillin, co-trimoxazole, ciprofloxacin and cefuroxime) against all tested Gram-negative rod isolates (excluding Morganella morgani and Acinetobacter spp. isolates). Fosfomycin also remained highly active against those isolates with extended spectrum β-lactamase (ESBL) production (95.8% in Escherichia coli isolates and 85.3% in Klebsiella pneumoniae isolates), unlike other tested per-oral antibiotics, which showed significant (p < 0.0001) susceptibility decrease. CONCLUSION: We have confirmed in the Czech Republic the very high susceptibility to fosfomycin trometamol of urinary tract infection pathogens, particularly Gram-negative rods including those producing β-lactamase. BioMed Central 2017-04-26 /pmc/articles/PMC5406914/ /pubmed/28446177 http://dx.doi.org/10.1186/s12894-017-0222-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Fajfr, Miroslav Louda, Miroslav Paterová, Pavla Ryšková, Lenka Pacovský, Jaroslav Košina, Josef Žemličková, Helena Broďák, Miloš The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study |
title | The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study |
title_full | The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study |
title_fullStr | The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study |
title_full_unstemmed | The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study |
title_short | The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study |
title_sort | susceptibility to fosfomycin of gram-negative bacteria isolates from urinary tract infection in the czech republic: data from a unicentric study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406914/ https://www.ncbi.nlm.nih.gov/pubmed/28446177 http://dx.doi.org/10.1186/s12894-017-0222-6 |
work_keys_str_mv | AT fajfrmiroslav thesusceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy AT loudamiroslav thesusceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy AT paterovapavla thesusceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy AT ryskovalenka thesusceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy AT pacovskyjaroslav thesusceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy AT kosinajosef thesusceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy AT zemlickovahelena thesusceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy AT brodakmilos thesusceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy AT fajfrmiroslav susceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy AT loudamiroslav susceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy AT paterovapavla susceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy AT ryskovalenka susceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy AT pacovskyjaroslav susceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy AT kosinajosef susceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy AT zemlickovahelena susceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy AT brodakmilos susceptibilitytofosfomycinofgramnegativebacteriaisolatesfromurinarytractinfectionintheczechrepublicdatafromaunicentricstudy |